No Password Required: CISO at RSA and Champion of a Passwordless Future
Podcast - Social Media Advertising and the FTC: Deception and the Architecture of Compliance
Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare
From Diligence to Post-Closing: What’s Shifting in 2026 Health Care Transactions
Legal AI in Practice: Firm Governance, Build vs. Buy Decisions, and Vendor Due Diligence — The Good Bot Podcast
From Showroom to Server Room: AI in Auto Finance — Moving the Metal: The Auto Finance Podcast
AI, Algorithms, and Accountability: Unpacking the Colorado AI Act with Senator Rodriguez — Regulatory Oversight Podcast
Navigate the Money Matrix in Our Upcoming Series: Privacy, Security, and AI Explained — The Consumer Finance Podcast
The Briefing: New York Times v. Perplexity AI: Copyright, Hallucinations, and Trademark Risk
No Password Required: Virtual CISO at Trace3 and Roller Derby Penalty Box Visitor
Building a Quantifiable Business Case for AI in Corporate Legal Departments
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 263: Building NC's Innovation Ecosystem with Andrea Conner of First Flight Venture Center
The Privacy Insider Podcast Episode 21: What Businesses Get Wrong About Regulators and How to Fix Privacy Fast
Identifying Good and Bad Use Cases for AI for Law Firms
Moving AI from Hype to Habit
AI's Impact on Litigation
Fintech Focus Podcast | Navigating Growth and Regulation: Lessons From Fintech Leadership
12 Days of Regulatory Insights: Day 9 – The Economic Development Edge — Regulatory Oversight Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 262: Breaking the “Undruggable” Barrier with Marcel Frenkel of Ten63 Therapeutics
Cybersecurity Insights for the Sandwich Generation with Dan Krutoy
Maine Governor Janet Mills recently allowed LD 61 – An Act to Regulate Employer Surveillance to Protect Workers – to become law without her signature. This law, which takes effect this summer, applies to all Maine employers,...more
Introduction and Summary - HHS issued a final rule modernizing 42 CFR Part 2 to implement the CARES Act and more closely align with HIPAA's Privacy, Breach Notification, and Enforcement frameworks. The rule permits a single,...more
The convergence of artificial intelligence (AI) and life sciences is no longer a distant promise. Companies operating in the sector are actively embracing the technology and are already achieving measurable results. In the...more
With the learnings of this report in mind, five priorities emerge for companies aiming to translate their AI ambitions into concrete, lasting advantage...more
1: AI is integral to business strategy - Three-quarters of life sciences companies say that AI is either crucial or very important to their business strategy. Within that, 68 percent of medical device companies and 56...more
Embracing AI is a strategic imperative for companies across the life sciences value chain, with the technology now a prerequisite for innovation, efficiency and future-readiness. The overwhelming consensus from our survey...more
AI is reshaping the life sciences industry in ways that are no longer hypothetical. The question is no longer whether to adopt AI, but how, and where, it can drive the most value. Adoption, however, is advancing at different...more
On January 14, 2026, President Trump issued a Presidential Proclamation adopting actions under the Section 232 investigation of advanced semiconductors, semiconductor manufacturing equipment, and derivative products....more
Across the life sciences sector, funding is being tied more closely to operational goals. Risk and legal teams are setting boundaries around data use, model oversight and accountability, while finance teams are unlocking...more
Throughout 2025, the Trump administration has tried to shape the direction of national AI policy through a series of executive orders and agency directives. In July 2025, President Trump’s issued the AI Action Plan along with...more
Agentic AI is here for in-house legal teams. In simplest terms, it’s the latest evolution of AI and moves beyond behind the scenes passive assistance to action-oriented agents that once created can operate for you to plan,...more
While the implementation of AI is growing apace, obstacles to deeper adoption still remain. These pressure points are consistent across subsectors: protecting sensitive data; integrating tools with legacy systems; clarifying...more
Cloud computing has been sold as elastic, on-demand access to virtually unlimited resources. However, the rapid growth of data-intensive and artificial intelligence–driven workloads has strained the availability of certain...more
With life sciences organizations moving from experimentation to implementation, AI is becoming a core enabler of innovation across the value chain. The technology is now supporting real-time decisions, and the scope of...more
The opening weeks of Washington’s 2026 legislative session have yielded a flurry of technology-focused bills spanning privacy, cybersecurity, artificial intelligence, online safety and data governance. While not all of these...more
As life sciences companies mature, intellectual property often becomes both their most valuable and most scrutinized asset. Whether you’re entering a collaboration, pursuing a crossover round, or preparing for acquisition,...more
Accenture’s planned acquisition of Faculty, announced on Jan. 6, 2026, significantly advances the global consulting firm’s AI‑capability buildout. According to statements from both companies, the transaction will bring more...more
Earlier this week, we released a +Insight called “Healthcare in 2026: A preview” that lays out major legislative and regulatory healthcare actions that we expect to see in 2026....more
U.S. states continue to crank out consumer privacy laws and regulations. Although only three new comprehensive consumer privacy laws are currently slated to take effect in 2026 (compared to the eight that took effect in...more
Securities class action filings remained elevated in 2025, signaling that robust activity will likely persist into 2026. According to economic and financial consulting company Cornerstone Research, through September 30, 2025,...more
On January 6, 2026, the US Food and Drug Administration (FDA) issued two revised guidance documents relating to general wellness products (General Wellness Guidance) and clinical decision support software (CDS Software...more
On January 6, 2026, the US Food and Drug Administration (FDA) revised its final guidance on Clinical Decision Support Software (2026 CDS Software Guidance)....more
At the end of 2024, we predicted that the healthcare mergers and acquisitions (M&A) market would pick up steam in 2025, given the combination of decreasing interest rates, a potential shift in the regulatory landscape with...more
Tokenization of private equity (PE) and venture capital (VC) fund interests is rapidly gaining traction in Asia, as fund managers and service providers seek to leverage blockchain technology to enhance liquidity, broaden...more
A federal judge has paused the merger of the only two companies developing a heart device made for high-risk patients suffering from aortic regurgitation, a potentially dangerous condition that occurs when the heart’s aortic...more